Trader’s Buzz: CytRx (CYTR), Sorrento Therapeutics (SRNE), BroadSoft, Inc. (BSFT), Tesla (TSLA), Aerie Pharmaceuticals (AERI)

Shares of CytRx Corporation (CYTR) are higher by nearly 30% to $4.79 in early trading on Monday after the company announced an interim analysis from its two ongoing phase 1b aldoxorubicin combination studies. The company said the combinations appear to be well tolerated, and even at the lowest dose level of aldoxorubicin, impressive tumor responses have […] View the full post at: Trader’s Buzz: CytRx (CYTR), Sorrento Therapeutics (SRNE), BroadSoft, Inc. (BSFT), Tesla (TSLA), Aerie Pharmaceuticals (AERI) Related posts: Insider Selling: Twitter (TWTR) CEO Unloads $5M Worth of Stock Phillips-Van Heusen Acquires Hilfiger for $3 Billion